West Pharmaceutical Services News

Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423

West Pharmaceutical Services (WST) has an average outperform rating and a price target range of $336 to $470, according to analysts polled by Capital IQ. Price: 364.09, Change: -4.09, Percent Change:

MT NewswiresApr 26 10:56 ET

West Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceApr 26 06:30 ET

Earnings Call Summary | West Pharmaceutical Services(WST.US) Q1 2024 Earnings Conference

The following is a summary of the West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript:Financial Performance:West Pharmaceutical Services reported a decrease in Q1 2024 net sales,

moomoo AIApr 26 05:26 ET · Conference Call

West Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy Rating

TipRanksApr 26 05:09 ET

West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceApr 26 03:12 ET

Express News | West Pharmaceutical Services Inc : Jefferies Raises Target Price to $426 From $423

ReutersApr 26 01:28 ET

West Pharmaceutical Services To Go Ex-Dividend On July 31st, 2024 With 0.2 USD Dividend Per Share

April 26th - $West Pharmaceutical Services(WST.US)$ is trading ex-dividend on July 31st, 2024. Shareholders of record on July 31st, 2024 will receive 0.2 USD dividend per share on August 7th, 2024

moomoo NewsApr 25 19:40 ET

West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript

West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsApr 25 17:42 ET

Research Alert: CFRA Maintains Hold Opinion On Shares Of West Pharmaceutical Services, Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain a 12-month target price of $

MT NewswiresApr 25 11:55 ET

Unusual Options Activity: GILD, DDOG and Others Attract Market Bets, GILD V/OI Ratio Reaches 1402.3

EST Apr 25th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.

moomoo NewsApr 25 11:30 ET

West Pharmaceutical Services Unveils Latest Financial Results

TipRanksApr 25 07:52 ET

West Pharmaceutical Services Q1 Net Income Declines; Increases 2024 Adj. EPS Guidance

RTTNewsApr 25 06:43 ET

West Pharma 1Q EPS, Sales Top Views as Inventory Issues Ease

By Rob Curran West Pharmaceutical Services said its first-quarter earnings and sales topped Wall Street views as inventory issues eased. The Exton, Pa.-based provider of products and services to dru

WSJApr 25 06:35 ET

Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, Vs. Street Est of $1.29

06:34 AM EDT, 04/25/2024 (MT Newswires) -- Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29

MT NewswiresApr 25 06:34 ET

Express News | West Pharmaceutical Services Raises Full-year 2024 Adjusted EPS Guidance To $7.63-$7.88, Compared Prior Range Of $7.50-$7.75 Versus Consensus Of $7.63

BenzingaApr 25 06:06 ET

West Pharmaceutical Services Earnings Beat by $0.26, Revenue Topped Estimates

InvestingApr 25 06:05 ET

Express News | West Pharmaceutical Services Reaffirms Full-year 2024 Net Sales Guidance of $3B-$3.025B Versus Consensus Of $3.01B

BenzingaApr 25 06:04 ET

Express News | West Pharmaceutical Outlook FY Net Sales USD 3,000-3,025 Million

ReutersApr 25 06:00 ET

Express News | West Pharmaceutical Q1 Adjusted EPS USD 1.56 Vs. Ibes Estimate USD 1.26

ReutersApr 25 06:00 ET

Express News | West Pharmaceutical Q1 EPS USD 1.55

ReutersApr 25 06:00 ET